Table 1 Model inputs
From: Podotimod in pediatric recurrent respiratory tract infections: a cost-utility analysis
Model input | Base case value | Distribution |
|---|---|---|
Probabilities | ||
Repeat episode of RTI | 0.20 | β (SD: 0.05) |
Mortality Repeat episode of RTI | 0,008 | β (SD: 0.001) |
Utility | ||
Case Base | 0.94 | β (SD: 0.01) |
Repeat episode of RTI | 0.87 | β (SD: 0.2) |
Cost | ||
Repeat episode of RTI (US$) | 2022 | Γ (SD: 505) |
Pidotimod × 60 Day (US$) | 196 | Γ (SD: 49) |
Pidotimod effectiveness | ||
Reduction of probability of Repeat RTI | 0,6 | LogN (SD: 0.03) |